Gene therapy trial partially restores eyesight
The full potential of the new therapy to cure blindness has yet to be realised. Keystone / Binsar Bakkara
A blind man has regained part of his sight after a new treatment genetically engineered his eye to produce light-sensitive algae proteins.
This content was published on May 25, 2021 - 11:32
May 25, 2021 - 11:32
swissinfo.ch/mga
The technique, known as optogenetics, was successfully trialled in France with input from the Institute of Molecular and Clinical Ophthalmology Basel (IOB), which is affiliated with the University of Basel.
Cells in the man’s retina were programmed to produce a protein called ChrimsonR, which is sensitive to light. The protein is naturally produced by algae to help them detect light.
Gene therapy trial partially restores eyesight swissinfo.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swissinfo.ch Daily Mail and Mail on Sunday newspapers.